Semisynthetic approaches to laspartomycin analogues

Journal of Natural Products

Volumn 70, Issue 3, 2007, Pages 447-450

  Curran, William V ^a   Leese, Richard A ^a   Jarolmen, Howard ^a   Borders, Donald B ^a   Dugourd, Dominique ^b   Chen, Yuchen ^b   Cameron, Dale R ^b  

^a BioSource Pharm Inc   (United States)

^b Migenix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ASPARTIC ACID; CARBAMIC ACID; LASPARTOMYCIN C; LIPOPEPTIDE; PEPTIDE; SULFONAMIDE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; UREA DERIVATIVE;

ACTINOPLANES UTAHENSIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM; BIOLOGICAL ACTIVITY; DRUG STRUCTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMIDOHYDROLASES; AMINOHYDROLASES; ANTI-BACTERIAL AGENTS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MICROMONOSPORACEAE; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; STAPHYLOCOCCUS AUREUS; TRYPTOPHAN; VANCOMYCIN RESISTANCE;

ACTINOPLANES UTAHENSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 34247159523     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np068062b     Document Type: Article

References (10)

1. (a) Naganawa, H.; Hamada, M.; Maeda, K.; Okami, Y.; Takeuchi, T.; Umezawa, H. J. Antibiot. 1968, 21, 55-62.
2. (b) Naganawa, H.; Takita, T.; Maeda, K.; Umezawa, H. J. Antibiot. 1970, 23, 423-424.
3. Borders, D. B.; Leese, R. A.; Jarolmen, H.; Francis, N. D.; Falla, T. Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 22-25, 2001, p 231, No. F-1154.
4. Kong, F.; Carter, G. T. J. Antibiot. 2003, 56, 557-564.
5. (a) Borders, D. B.; Francis, N. D.; Simon, R. J.; Fantini, A. A. Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 22-25, 2001, p 231, No. F-1156.
6. (b) Borders, D. B.; Leese, R. A.; Jarolmen, H.; Francis, N. D.; Fantini, A. A.; Falla, T.; Fiddes, J. C.; Aumelas A. J. Nat. Prod. 2007, 70, XXXXX.
7. Simon, R. J.; Curran, W. V.; Leese, R. A.; Borders, D. B.; Koontz M. Z.; Lui, H. Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 22-25, 2001, p 231, No. F-1155.
8. Cameron, D. R.; Chen, Y.; Dugourd, D.; Sun, J.; Wang, L.; Borders, D. B.; Curran, W. V.; Leese, R. A. Abstracts of Papers, 229th ACS National Meeting, San Diego, CA, March 13-17, 2005; MEDI-358.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Document M7-A6; National Committee for Clinical Laboratory Standards: Wayne, PA, 2003.
10. Bunkóczl, G.; Vértesy, L.; Sheldrick, G. M. Acta Crystallogr. 2005, D61, 1160-1164.